Paul J. Leibowitz
10Patents
7h-index
8Co-inventors
55Inventor score
Filing activity: Dec 29, 1980 → Jun 7, 1995
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5720936A | Transgenic mouse assay for compounds affecting amyloid protein processing | Chemistry; Metallurgy | 55 | Expired |
| US5811633A | Transgenic mouse expressing APP.sub.770 | Chemistry; Metallurgy | 54 | Expired |
| US4315852A | Extraction of interferon from bacteria | Emerging Cross-Sectional Technologies | 31 | Expired |
| US5122457A | Expression systems utilizing bacteriophage T7 promoters, gene sequences, and T7 RNA polymerase | Chemistry; Metallurgy | 24 | Expired |
| US4892743A | Novel hybrid interferon species | Human Necessities | 21 | Expired |
| US4364863A | Extraction of interferon from bacteria | Emerging Cross-Sectional Technologies | 10 | Expired |
| US4958007A | Extraction of human interleukin-4- from bacteria | Emerging Cross-Sectional Technologies | 8 | Expired |
| US4806347A | Interferon combinations | Emerging Cross-Sectional Technologies | 4 | Expired |
| US4912200A | Extraction of granulocyte macrophage colony stimulating factor from bacteria | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5136024A | Extraction of granulocyte macrophage colony stimulating factor from bacteria | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.